More importantly, DDIT4 is described as an independent indicator for a poor prognosis in several malignancies [34], such as acute myeloid leukemia, breast cancer, glioblastoma multiforme, colon, skin and lung cancer. This evidence concerns the gene DDIT4 and acute myeloid leukemia.